New hope for long COVID's debilitating fatigue?
Symptom relief
Not yet recruiting
This study is testing whether an investigational drug called sonlicromanol can reduce severe fatigue in people with post-COVID condition, specifically those who experience a major worsening of symptoms after physical or mental effort (post-exertional malaise). It will involve 80 …
Phase: PHASE2 • Sponsor: Michele van Vugt • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC